'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Malaria to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Malaria to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Malaria Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Malaria 30
Nov 28, 2017: GSK Submits US Regulatory Application for Single-dose Tafenoquine for Plasmodium vivax Malaria 30
Clinical Trial Profile Snapshots 31
Appendix 599
Abbreviations 599
Definitions 599
Research Methodology 600
Secondary Research 600
About GlobalData 601
Contact Us 601
Source 601
List of Tables
Malaria Therapeutics, Global, Clinical Trials by Region, 2017* 7
Malaria Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Malaria Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Malaria Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
Malaria Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Malaria Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Malaria Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 13
Malaria Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 14
Proportion of Malaria to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 15
Malaria Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Malaria Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Malaria to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 18
Malaria Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Malaria Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Malaria Therapeutics, Global, Clinical Trials by Phase, 2017* 21
Malaria Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
Malaria Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Malaria Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Malaria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Malaria Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
Malaria Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Malaria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Malaria Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
List of Figures
Malaria Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Malaria Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Malaria Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Malaria Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
Malaria Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Malaria Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Malaria Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 13
Malaria Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 14
Proportion of Malaria to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 15
Malaria Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Malaria Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Malaria to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 18
Malaria Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Malaria Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Malaria Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
Malaria Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
Malaria Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Malaria Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Malaria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Malaria Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
Malaria Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Malaria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Malaria Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
GlobalData Methodology 600